Don't let great ideas die over and over again because they're not being sold well.
___
This is part of a series of posts by LUCENT biopharma – focused on the future of medicines and their marketing in the biopharma sector.
For more information, please go to www.lucentbiopharma.com
With endless meetings, incessant emails, and casts of thousands, companies have mastered the art of unnecessary interactions. Winning in the next normal requires much more focus on true collaboration.
There’s a topic that’s come up over and again in the past few weeks - the question of compensation for members of your medical department and in particular - annual bonuses. There's a thousand differe
You don’t need to look far to find predictions of ‘the end of the sales-force era’ in biopharma. I first heard this in February 2004 about a week after starting my first job in large pharma. I won’t r
